Osteogenic activity of natural diterpenoids isolated from Cupressus sempervirens fruits in calvarial derived osteoblast cells via differentiation and mineralization

Phytomedicine

Volumn 21, Issue 14, 2014, Pages 1794-1800

  Faheem Khan, Mohammad ^a   Dev, Kapil ^a   Lahiri, Shibani ^a   Dixit, Manisha ^a   Trivedi, Ritu ^a   Singh, Divya ^a   Maurya, Rakesh ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Alkaline phosphatase; Cupressus sempervirens; Diterpenoids; Osteoblast differentiation; Osteoporosis; Sugiol

Indexed keywords

15 ACETOXY IMBRICATOLIC; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COMMUNIC ACID; DAIDZEIN; DITERPENOID; IMBRICATOLIC ACID; SUGIOL; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; BMP2 PROTEIN, MOUSE; DITERPENE; RUNX2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE DEVELOPMENT; BONE STRENGTH; CELL DIFFERENTIATION; COMPRESSION FRACTURE; CONTROLLED STUDY; CUPRESSUS; CUPRESSUS SEMPERVIRENS; DRUG ISOLATION; FEMALE; FEMUR; FEMUR EPIPHYSIS; FRUIT; MARKER GENE; MINERALIZATION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; TRABECULAR BONE; UTERUS; ANIMAL; BAGG ALBINO MOUSE; BONE MINERALIZATION; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; METABOLISM; OVARIECTOMY; SKULL;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CUPRESSUS; DITERPENES; FEMALE; FRUIT; MICE; MICE, INBRED BALB C; MOLECULAR STRUCTURE; OSTEOBLASTS; OSTEOGENESIS; OVARIECTOMY; SKULL;

EID: 84910078445     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2014.09.004     Document Type: Article

References (32)

1. Allen, J.G., Fotsch, C., Babij, P., 2010. Emerging targets in osteoporosis disease modification. J. Med. Chem. 53, 4332-4353.
2. Aoki, K., Saito, H., Itzstein, C., Ishiguro, M., Shibata, T., Blanque, R., 2006. A TNF receptor loop peptide mimics blocks RANK ligand-induced signaling, bone resorption, and bone loss. J. Clin. Invest. 116, 1525-1534.
3. Bhargava, B., Gautam, A.K., Singh, D., Kumar, A., Chaurasia, S., Tyagi, A.M., Yadav, D.K., Mishra, J.S., Singh, A.B., Sanyal, S., Goel, A., Maurya, R., Chattopadhyay, N., 2009. Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling. J. Cell. Biochem. 108, 388-399.
4. Christel, P., Coxam, V., Catherine, B.P., Séraphin, K.C., Davicco, M.J., Lebecque, P., Barlet, J.P., 2000. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J. Nutr. 130, 1675-1681.
5. Cuong, N.X., Tuan, T.A., Kiem, P.V., Minh, C.V., Choi, C.M., Kim, Y.H., 2008. New cembroid diterpenes from the Vietnamese soft coral Sarcophyton mililatensis stimulate osteoblastic differentiation in MC3T3-E1 cells. Chem. Pharmacol. Bull. 56, 988-992.
6. Dao, T.T., Lee, K.Y., Jeong, H.M., Nguyen, P.H., Tran, T.L., Thuong, P.T., Nguyen, B.T., Oh, W.K., 2011. ent-Kaurane diterpenoids from Croton tonkinensis stimulate osteoblast differentiation. J. Nat. Prod. 74, 2526-2531.
7. Dixit, P., Chand, K., Khan, M.P., Siddiqui, J.A., Tewari, D., Ngueguim, F.T., Chattopadhyay, N., Maurya, R., 2012. Phytoceramides and acylated phytosterol glucosides from Pterospermum acerifolium Willd. seed coat and their osteogenic activity. Phytochemistry 81, 117-125.
8. Khan, M.F., Kumar, M., Jaiswal, N., Srivastava Arvind Maurya, R., 2010. α-Glucosidase inhibitor constituents from the Bombax ceiba. Trends Carbohydr. Res. 2, 29-34.
9. Kumar, M., Rawat, P., Dixit, P., Mishra, D., Gautam, A.K., Pandey, R., Singh, D., Chattopadhyay, N., Maurya, R., 2010. Anti-osteoporotic constituents from Indian medicinal plants. Phytomedicine 17, 993-999.
10. Gautam, A.K., Bhargavan, B., Tyagi, A.M., Srivastava, K., Yadav, D.K., Kumar, M., Akanksha Mishra, J.S., Singh, A.B., Sanyal, S., Maurya, R., Mackivasagam, L., Singh, S.P., Wahajuddin Jain, G.K., Chattopadhyay, N., Singh, D., 2011. Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats. J. Nutr. Biochem. 22, 318-327.
11. Han, C.Y.E., Wang, Y., Yu, L., Powers, D., Xiong, X., Yu, V., Nguyen, Y., Jean Jr., D.J.S., Babij, P., 2009. Small molecules with potent osteogenic inducing activity in osteoblast cells. Bioorg. Med. Chem. Lett. 19, 1442-1445.
12. Lane, N.E., Kumer, J.L., Majumdar, S., Khan, M., Lotz, J., Stevens, R.E., Klein, R., Phelps, K.V., 2002. The effects of synthetic conjugated estrogens, a (cenestin) on trabecularbone structure and strength in the ovariectomized rat model. Osteoporos. Int. 13, 816-823.
13. Legrand, E., Chappard, D., Pascaretti, C., Duquenne, M., Krebs, S., Rohmer, V., Basle, M.F., Audran, M., 2000. Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis. J. Bone Miner. Res. 15, 13-19.
14. Lo, Y.C., Chang, Y.H., Wei, B.L., Huang, Y.L., Chiou, W.F., 2010. Betulinic acid stimulates the differentiation and mineralization of osteoblastic MC3T3-E1 cells: involvement of BMP/Runx2 and β-catenin signals. J. Agric. Food Chem. 58, 6643-6649.
15. Maurya, R., Yadav, D.K., Singh, G., Bhargavan, B., Narayana, M.P.S., Sahai, M., Singh, M.M., 2009. Osteogenic activity of constituents from Butea monosperma. Bioorg. Med. Chem. Lett. 19, 610-613.
16. Narducci, P., Bareggi, R., Nicolin, V., 2009. Interaction of human recombinant tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin could contribute to enhancement of the erosive processes induced by human synovial cells. J. Rheumatol. 36, 1837-1839.
17. Nicolin, V., Dal Piaz, F., Nori, S.L., Narducci, P.N., Tommasi, D., 2010. Inhibition of bone resorption by Tanshinone VI isolated from Salvia miltiorrhiza Bunge. Eur. J. Histochem. 54, 104-106, e21.
18. Omeje, E.O., Khan, M.P., Osadeb, P.O., Tewari, D., Khan, M.F., Dev, K., Maurya, R., Chattopadhyay, N., 2014. Analysis of constituents of the eastern Nigeria mistletoe, Loranthus micranthus Linn. revealed presence of new classes of osteogenic compounds. J. Ethnopharmacol. 151, 643-651.
19. Pandey, R., Gautam, A.K., Biju, B., Trivedi, R., Swarnkar, G., Nagar, G.K., Yadav, D.K., Kumar, M., Rawat, P., Manickavasagam, L., Maurya, R., Goel, A., Jain, G.K., Chattopadhyay, N., Singh, D., 2010. Total extract and standardized fraction from the stem-bark of Butea monosperma have osteoprotective action: evidence for the non-estrogenic osteogenic effect of the standardized fraction. Menopause 17, 602-610.
20. 3 antagonists for the prevention and treatment of osteoporosis. J. Med. Chem. 47, 4829-4837.
21. Qiu, S.X., Dan, C., Ding, L.S., Peng, S., Chen, S.N., Farnsworth, N.R., Nolta, J., Gross, M.L., Zhou, P., 2007. A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNF-α signaling pathways. Chem. Biol. 14, 860-869.
22. Rawat, P., Khan, M.F., Kumar, M., Tamarkar, A.K., Srivastava, A.K., Arya, K.R., Maurya, R., 2010. Constituents from fruits of Cupressus sempervirens. Fitoterapia 81, 162-166.
23. Rawat, P., Kumar, M., Sharan, K., Chattopadhyay, N., Maurya, R., 2009. Ulmosides A and B: flavonoid 6-C-glycosides from Ulmus wallichiana, stimulating osteoblast differentiation assessed by alkaline phosphatase. Bioorg. Med. Chem. Lett. 19, 4684-4687.
24. Rodan, G.A., Martin, T.J., 2000. Therapeutic approaches to bone diseases. Science 289, 1508-1514.
25. Siddiqui, J.A., Swarnkar, G., Sharan, K., Chakravarti, B., Sharma, G., Rawat, P., Kumar, M., Khan, F.M., Pierroz, D., Maurya, R., Chattopadhyay, N., 2010. 8,8″-Biapigeninyl stimulates osteoblast functions and inhibits osteoclast and adipocyte functions: Osteoprotective action of 8,8″-biapigeninyl in ovariectomized mice. Mol. Cell. Endocrinol. 323, 256-267.
26. Takada, Y., Ichikawa, H., Badmaev, V., Aggarwal, B.B., 2006. Acetyl-11-keto-beta- boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NFkappa B-regulated gene expression. J. Immunol. 176, 3127-3140.
27. Trivedi, R., Kumar, A., Gupta, V., Kumar, S., Nagar, G.K., Romero, J.R., Dwivedi, A.K., Chattopadhyay, N., 2009. Effects of Egb 761 on bone mineral density, bone microstructure, and osteoblast function: possible roles of quercetin and kaempferol. Mol. Cell. Endocrinol. 302, 86-91.
28. Tyagi, A.M., Gautam, A.K., Kumar, A., Srivastava, K., Bhargavan, B., Trivedi, R., Saravanan, S., Yadav, D.K., Singh, N., Pollet, C., Brazier, M., Mentaverri, R., Maurya, R., Chattopadhyay, N., Goel, A., Singh, D., 2010. Medicarpin inhibits osteoclastogenesis and has nonestrogenic bone conserving effect in ovariectomized mice. Mol. Cell. Endocrinol. 325, 101-109.
29. Tyagi, A.M., Srivastava, K., Mansoori, M.N., Trivedi, R., Chattopadhyay, N., Singh, D., 2012. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. PLoS ONE 7 (9), e44552.
30. Tyagi, A.M., Srivastava, K., Sharan, K., Yadav, D.K., Maurya, R., Singh, D., 2011. Daidzein prevents the increase in CD4+CD28null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect. PLoS ONE 6 (6), e21216.
31. Xu, J., Li, Z., Luo, J., Yang, F., Liu, T., Liu, M., Qiu, W.-W., Tang, J., 2012. Synthesis and biological evaluation of heterocyclic ring-fused betulinic acid derivatives as novel inhibitors of osteoclast differentiation and bone resorption. J. Med. Chem. 55, 3122-3134.
32. Zhai, Z.J., Li, H.W., Liu, G.W., Qu, X.H., Tian, B., Yan, W., Lin, Z., Tang, T.T., Qin, A., Dai, K.R., 2014. Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo. Br. J. Pharmacol. 171, 663-675.